Recent

% | $
Quotes you view appear here for quick access.

Protalix BioTherapeutics, Inc. (PLX) Message Board

  • suzycat717 suzycat717 May 2, 2012 7:12 PM Flag

    Multiple errors in Seeking Alph article.

    FIrst off...NO ONE values an early stage developing biotech on a p/e ratio..
    even so...applying an 8 p/e is just plain ridiculous...not even utilities
    trade at that multiple...so p/e analysis invalidates your thesis...
    They are always priced at a multiple to sales...
    THeir discovery platform is also ignored in your analysis as well as their
    pipeline...you may want to look at BMRN as an example of a platform discovery
    company...current rev's 566mm...operating losses still in 2012 and 2013...
    market cap $4.1 BB....roughly 7x sales...price 35...(you would argue it should be sub $5)
    your "analysis" is seriously flawed and I pity anyone who may listen to you..
    Short away my friend....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
PLX
0.61-0.0064(-1.04%)Aug 26 4:00 PMEDT